Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy
Introduction The risk of bleeding has led to screening of the primary hemostasis before renal biopsy. A bleeding time test (BT) is considered standard practice, but reliance on this test is controversial and its benefits remain questionable. A possible alternative is thromboelastography (TEG). Howev...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/0886022X.2019.1700805 |
| _version_ | 1819163764046430208 |
|---|---|
| author | Amir Gal-Oz Amitay Papushado Ilya Kirgner Shmuel Meirsdorf Doron Schwartz Idit Francesca Schwartz Asia Zubkov Ayelet Grupper |
| author_facet | Amir Gal-Oz Amitay Papushado Ilya Kirgner Shmuel Meirsdorf Doron Schwartz Idit Francesca Schwartz Asia Zubkov Ayelet Grupper |
| author_sort | Amir Gal-Oz |
| collection | DOAJ |
| description | Introduction The risk of bleeding has led to screening of the primary hemostasis before renal biopsy. A bleeding time test (BT) is considered standard practice, but reliance on this test is controversial and its benefits remain questionable. A possible alternative is thromboelastography (TEG). However, data regarding TEG in patients with renal dysfunction is limited. Objectives To determine TEG abnormalities and their consequences in patients who underwent a native kidney biopsy. Methods A retrospective study of 417 consecutive percutaneous native renal biopsies performed in our Center. If serum creatinine >1.5 mg/dL, the patient underwent either a BT test (period A, January 2015–31 December 2016) or TEG (period B, January 2017–August 2018). In patients with prolonged BT, or an abnormal low maximal amplitude (MA) parameter of TEG, or suspected clinical uremic thrombopathy, the use of desmopressin acetate (DDAVP) was considered. Results Most biopsies (90.6%) were done by the same dedicated radiologist. Fifty-one patients had a BT test, which was normal in all tested patients. Seventy-one patients underwent TEG, and it was abnormal in 34 of them, most patients had combined abnormalities. The only parameter related to abnormal TEG was older age (Odds Ratio 1.21 [95% CI 1.09–2.38] p = 0.04 for abnormal Kinetics; OR 1.37 (1.05–1.96) p = 0.037 for abnormal MA). Twenty-six patients (6.23%) had bleeding complications. Risk of bleeding was significantly related to age (1.4 [1.11–7.48] p = 0.04), systolic blood pressure (1.85 [1.258–9.65] p = 0.02), and serum creatinine (1.21 [1.06–3.134] p = 0.048). Conclusions TEG abnormalities in patients with renal dysfunction are variable and fail to predict bleeding during kidney biopsy. The decision to administer DDAVP as a preventive measure during these procedures should be based on clinical judgment only. |
| first_indexed | 2024-12-22T17:49:19Z |
| format | Article |
| id | doaj.art-767f94afaf2f454884a0bbd2fa7cc248 |
| institution | Directory Open Access Journal |
| issn | 0886-022X 1525-6049 |
| language | English |
| last_indexed | 2024-12-22T17:49:19Z |
| publishDate | 2020-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj.art-767f94afaf2f454884a0bbd2fa7cc2482022-12-21T18:18:13ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492020-01-01421101810.1080/0886022X.2019.17008051700805Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsyAmir Gal-Oz0Amitay Papushado1Ilya Kirgner2Shmuel Meirsdorf3Doron Schwartz4Idit Francesca Schwartz5Asia Zubkov6Ayelet Grupper7ICU Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityDepartment of Internal Medicine “B”, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityHematology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityRadiology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityPathology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityNephrology Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv UniversityIntroduction The risk of bleeding has led to screening of the primary hemostasis before renal biopsy. A bleeding time test (BT) is considered standard practice, but reliance on this test is controversial and its benefits remain questionable. A possible alternative is thromboelastography (TEG). However, data regarding TEG in patients with renal dysfunction is limited. Objectives To determine TEG abnormalities and their consequences in patients who underwent a native kidney biopsy. Methods A retrospective study of 417 consecutive percutaneous native renal biopsies performed in our Center. If serum creatinine >1.5 mg/dL, the patient underwent either a BT test (period A, January 2015–31 December 2016) or TEG (period B, January 2017–August 2018). In patients with prolonged BT, or an abnormal low maximal amplitude (MA) parameter of TEG, or suspected clinical uremic thrombopathy, the use of desmopressin acetate (DDAVP) was considered. Results Most biopsies (90.6%) were done by the same dedicated radiologist. Fifty-one patients had a BT test, which was normal in all tested patients. Seventy-one patients underwent TEG, and it was abnormal in 34 of them, most patients had combined abnormalities. The only parameter related to abnormal TEG was older age (Odds Ratio 1.21 [95% CI 1.09–2.38] p = 0.04 for abnormal Kinetics; OR 1.37 (1.05–1.96) p = 0.037 for abnormal MA). Twenty-six patients (6.23%) had bleeding complications. Risk of bleeding was significantly related to age (1.4 [1.11–7.48] p = 0.04), systolic blood pressure (1.85 [1.258–9.65] p = 0.02), and serum creatinine (1.21 [1.06–3.134] p = 0.048). Conclusions TEG abnormalities in patients with renal dysfunction are variable and fail to predict bleeding during kidney biopsy. The decision to administer DDAVP as a preventive measure during these procedures should be based on clinical judgment only.http://dx.doi.org/10.1080/0886022X.2019.1700805thromboelastography kidney biopsyuremic bleedingrenal failure |
| spellingShingle | Amir Gal-Oz Amitay Papushado Ilya Kirgner Shmuel Meirsdorf Doron Schwartz Idit Francesca Schwartz Asia Zubkov Ayelet Grupper Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy Renal Failure thromboelastography kidney biopsy uremic bleeding renal failure |
| title | Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy |
| title_full | Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy |
| title_fullStr | Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy |
| title_full_unstemmed | Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy |
| title_short | Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy |
| title_sort | thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy |
| topic | thromboelastography kidney biopsy uremic bleeding renal failure |
| url | http://dx.doi.org/10.1080/0886022X.2019.1700805 |
| work_keys_str_mv | AT amirgaloz thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT amitaypapushado thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT ilyakirgner thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT shmuelmeirsdorf thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT doronschwartz thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT iditfrancescaschwartz thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT asiazubkov thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy AT ayeletgrupper thromboelastographyversusbleedingtimeforriskofbleedingpostnativekidneybiopsy |